Products April 8, 2010
ProShares Launches Leveraged and Inverse Biotechnology ETFs
April 8, 2010 (PLANSPONSOR.com) – ProShares has launched ETFs with
leveraged and inverse exposure to the biotechnology sector.
Reported by Rebecca Moore
The Ultra Nasdaq Biotechnology (BIB) and UltraShort Nasdaq Biotechnology (BIS), will listed on NASDAQ Thursday.
The Ultra Nasdaq Biotechnology seeks investment results that correspond to twice (200%) the performance of the NASDAQ Biotechnology Index for a single day, before fees and expenses, while the UltraShort Nasdaq Biotechnology is built to produce 200% of the inverse performance of the NASDAQ Biotechnology Index for a single day, before fees and expenses.
More information is at http://www.proshares.com.